Cargando…
Technical success, clinical efficacy, and insight into the causes of restenosis after the percutaneous coronary intervention of de novo coronary artery lesions using a paclitaxel-coated balloon with citrate ester excipient
OBJECTIVES: The aim of this all-comers registry study was to investigate the technical success, clinical efficacy, and safety of a drug-coated balloon (DCB) with paclitaxel combined with citrate ester excipient (CEE) in percutaneous coronary intervention (PCI) of de novo coronary lesions in an all-c...
Autores principales: | Tervo, Jerry, Kärkkäinen, Jussi M., Rissanen, Tuomas T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662788/ https://www.ncbi.nlm.nih.gov/pubmed/36386336 http://dx.doi.org/10.3389/fcvm.2022.1012473 |
Ejemplares similares
-
No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter
por: Chung, Han-Hee, et al.
Publicado: (2012) -
Comparison of 2 Different Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis: A Randomized Controlled Trial
por: Jun, Eun Jung, et al.
Publicado: (2022) -
Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions
por: Her, Ae-Young, et al.
Publicado: (2016) -
Excimer laser coronary atherectomy prior to paclitaxel-coated balloon angioplasty for de novo coronary artery lesions
por: Shibui, Takashi, et al.
Publicado: (2020) -
In vitro and in vivo Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons
por: Turner, Emily, et al.
Publicado: (2018)